__NUXT_JSONP__("/drugs/Rineterkib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1715025-32-3",chebiId:b,chemicalFormula:b,definition:"An orally available inhibitor of extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon oral administration, rineterkib binds to and inhibits ERK, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)\u002FERK pathway is upregulated in numerous tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival.",fdaUniiCode:"15KFN616FK",identifier:"C126687",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C174048"],synonyms:["ERK Inhibitor LTT462","LTT 462","LTT462","RINETERKIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FRineterkib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Rineterkib","","2021-10-30T13:30:48.283Z")));